Occupational disparities in tumor grade and cytosolic HMGB1 expression in renal cell cancer
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Occupational Health"
DOI: 10.1002/1348-9585.12340
Abstract: We sought to examine occupational disparities in tumor grade and cytosolic expression of high‐mobility group box‐1 (HMGB1) among renal cell cancer (RCC) patients. read more here.
Keywords: grade cytosolic; renal cell; cell cancer; occupational disparities ... See more keywords
Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of esophageal squamous cell cancer patients undergoing minimally invasive esophagectomy after neoadjuvant chemotherapy.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of surgical oncology"
DOI: 10.1002/jso.26611
Abstract: BACKGROUND One of the primary treatment for resectable advanced esophageal squamous cell cancer (ESCC) is neoadjuvant chemotherapy (NAC) followed by minimally invasive esophagectomy (MIE). Because the neutrophil-to-lymphocyte ratio (NLR) is a widely reported prognostic factor… read more here.
Keywords: invasive esophagectomy; minimally invasive; squamous cell; cell cancer ... See more keywords
CircBFAR correlates with poor prognosis and promotes laryngeal squamous cell cancer progression through miR‐31‐5p/COL5A1 axis
Sign Up to like & getrecommendations! Published in 2022 at "Laryngoscope Investigative Otolaryngology"
DOI: 10.1002/lio2.966
Abstract: Laryngeal squamous cell cancer (LSCC) is a highly malignant tumor originating from the respiratory system. Circular RNAs have been reported to be associated with the treatment and prognosis of a variety of cancers, including LSCC. read more here.
Keywords: cell cancer; squamous cell; prognosis; laryngeal squamous ... See more keywords
Surgical Protocols for Squamous Cell Cancer of the Esophagus.
Sign Up to like & getrecommendations! Published in 2020 at "Methods in molecular biology"
DOI: 10.1007/978-1-0716-0377-2_25
Abstract: Surgery is the mainstay treatment for esophageal squamous cell carcinoma (ESCC). A major development in surgical therapy for esophageal cancer in the past two or three decades has been the marked reduction in surgical mortality… read more here.
Keywords: cancer esophagus; surgical protocols; squamous cell; cell cancer ... See more keywords
Second-line therapy in metastatic renal cell cancer—how do we treat after immuno-oncology drugs?
Sign Up to like & getrecommendations! Published in 2019 at "memo - Magazine of European Medical Oncology"
DOI: 10.1007/s12254-019-00545-4
Abstract: The treatment landscape of metastatic renal cell cancer (mRCC) is rapidly evolving. To date in 2019 twelve drugs are licensed for this indication, two more drugs are awaited to be introduced into our portfolio of… read more here.
Keywords: renal cell; line; treatment; cell cancer ... See more keywords
Metastatic Renal Cell Cancer—Systemic Therapy
Sign Up to like & getrecommendations! Published in 2018 at "Indian Journal of Surgical Oncology"
DOI: 10.1007/s13193-018-0721-2
Abstract: Management of metastatic renal cell carcinoma (mRCC) has evolved considerably in the past 10 years due to better understanding of tumor biology. This development has changed mRCC to a chronic progressive disease with several lines of… read more here.
Keywords: renal cell; cell cancer; metastatic renal; cancer systemic ... See more keywords
Prospective study of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced renal cell cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Immunology letters"
DOI: 10.1016/j.imlet.2017.03.004
Abstract: In this study, the clinical efficacy of cryosurgery combined with allogenic NK cell immunotherapy for advanced renal cell cancer was evaluated. From July to December 2016, we enrolled 60 patients who met the enrollment criteria… read more here.
Keywords: renal cell; cell cancer; combined allogenic; cell ... See more keywords
Treatment of cutaneous leiomyomas with 5% lidocaine patches in a patient with hereditary leiomyomatosis and renal cell cancer (Reed syndrome)
Sign Up to like & getrecommendations! Published in 2017 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2017.06.007
Abstract: Hereditary leiomyomatosis and renal cell cancer (HLRCC) (formerly known as Reed syndrome, multiple cutaneous and uterine leiomyomatosis, leiomyomatosis cutis et uteri, and multiple leiomyomatosis) is an autosomal dominant syndrome comprising cutaneous leiomyomas, uterine leiomyomas, or… read more here.
Keywords: renal cell; hereditary leiomyomatosis; cutaneous leiomyomas; leiomyomatosis renal ... See more keywords
The cell of cancer origin provides the most reliable roadmap to its diagnosis, prognosis (biology) and therapy.
Sign Up to like & getrecommendations! Published in 2021 at "Medical hypotheses"
DOI: 10.1016/j.mehy.2021.110704
Abstract: Cancers arise from single transformed cells from virtually every organ of the body, divide in a relatively uncontrolled manner, and metastasize widely. A search for a "magic bullet" to precisely diagnose, characterize, and ultimately treat… read more here.
Keywords: provides reliable; cancer origin; cell cancer; biology ... See more keywords
Nanomaterials for T-cell cancer immunotherapy
Sign Up to like & getrecommendations! Published in 2021 at "Nature Nanotechnology"
DOI: 10.1038/s41565-020-00822-y
Abstract: T-cell-based immunotherapies hold promise for the treatment of many types of cancer, with three approved products for B-cell malignancies and a large pipeline of treatments in clinical trials. However, there are several challenges to their… read more here.
Keywords: cell cancer; cancer immunotherapy; cancer; cell ... See more keywords
The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
Sign Up to like & getrecommendations! Published in 2020 at "Nature Immunology"
DOI: 10.1038/s41590-020-0728-z
Abstract: Natural killer (NK) cells belong to the innate immune system and contribute to protecting the host through killing of infected, foreign, stressed or transformed cells. Additionally, via cellular cross-talk, NK cells orchestrate antitumor immune responses.… read more here.
Keywords: cancer cycle; cell cancer; cell based; biology ... See more keywords